Blood Collection Tubes Market Size, Share, Trends, Growth Report 2034

Blood Collection Tubes Industry Prospective:

The global blood collection tubes market size was worth approximately USD 6.91 billion in 2024 and is projected to grow to around USD 12.92 billion by 2034, with a compound annual growth rate (CAGR) of roughly 6.55% between 2025 and 2034.

Request Free Sample

Key Insights

• As per the analysis shared by our research analyst, the global blood collection tubes market is estimated to grow annually at a CAGR of around 6.55% over the forecast period (2025-2034).
• In terms of revenue, the global blood collection tubes market size was valued at approximately USD 6.91 billion in 2024 and is projected to reach USD 12.92 billion by 2034.
• The blood collection tubes market is projected to grow significantly due to rising healthcare expenditure, expanding diagnostic laboratory networks, growing elderly populations requiring regular health monitoring, and increasing awareness about preventive healthcare.
• Based on product type, the serum separating tubes segment is expected to lead the blood collection tubes market, while the plasma separation tubes segment is anticipated to experience significant growth.
• Based on material, the plastic segment is expected to lead the blood collection tubes market, while the PET material segment is anticipated to witness notable growth.
• Based on application, the diagnostic testing segment is the dominating segment, while the molecular diagnostics segment is projected to witness sizeable revenue over the forecast period.
• Based on end-user, the diagnostic laboratories segment is expected to lead the market compared to the home healthcare segment.
• Based on region, North America is projected to dominate the global blood collection tubes market during the estimated period, followed by Europe.

Blood Collection Tubes Market: Overview

A blood collection tube is a sterile glass or plastic medical device used to collect, store, and transport blood samples for laboratory testing and diagnostic procedures. These tubes include specific additives such as anticoagulants, clot activators, or preservatives to protect sample quality during handling and analysis. Color-coded caps identify tube functions, helping healthcare professionals select the correct tubes for required tests without errors. Vacuum-sealed design draws a fixed blood volume automatically, improving consistency and reducing collection time. Serum separator tubes use gel barriers to separate serum from cells during centrifugation for accurate analysis.

EDTA tubes stop clot formation by binding calcium and support complete blood count and hematology testing. Heparinized tubes are used to collect plasma samples for clinical chemistry, electrolyte testing, and urgent diagnostics. Diagnostic laboratories and blood banks use blood collection tubes for chemistry, immunology, microbiology, molecular testing, donor screening, and blood typing. Hospitals and clinics maintain multiple tube types for emergency care, surgery, intensive care, and outpatient services. Strict manufacturing standards ensure sterility, additive accuracy, vacuum stability, and material safety. Global distribution networks supply healthcare facilities worldwide.

The increasing prevalence of chronic diseases and growing diagnostic testing volumes are expected to drive growth in the blood collection tubes market throughout the forecast period.

Blood Collection Tubes Market Dynamics

Growth Drivers

How is chronic disease prevalence driving the growth of the blood collection tubes market?

The blood collection tubes market grows steadily as chronic diseases like diabetes, heart disease, cancer, and kidney disorders require frequent blood testing. Diabetes care depends on regular blood glucose, hemoglobin A1c, and lipid tests, driving repeated laboratory visits across global patient populations. Cardiovascular screening programs use blood tests for cholesterol, triglycerides, cardiac enzymes, and inflammation markers to detect risk early. Cancer diagnosis and treatment monitoring rely on blood tests for tumor markers, blood counts, and organ function during therapy cycles.

Chronic kidney disease management requires frequent testing for creatinine, electrolytes, and filtration levels as disease severity progresses. Aging populations and rising obesity rates increase long-term blood monitoring for metabolic disorders, liver conditions, and cardiovascular risks. Management of hypertension and autoimmune diseases requires periodic blood testing to monitor medication safety, disease activity, and organ function. Chronic infection care for HIV and hepatitis depends on routine blood tests supporting viral load monitoring and immune system assessment.

Preventive healthcare adoption is creating new opportunities.

The global blood collection tubes market grows due to rising focus on preventive care, routine health screenings, and early disease detection through blood testing. Corporate wellness programs offer employee screenings using metabolic panels, complete blood counts, and lipid profiles, identifying health risks before symptoms appear. Insurance providers encourage preventive testing by offering lower premiums and wellness incentives for annual checkups and recommended blood tests.

Government health programs promote screening for diabetes and cholesterol using public campaigns, expanding routine blood testing among high-risk populations. Direct-to-consumer laboratory testing improves access by allowing individuals to order blood tests independently, supporting wider market adoption. Wellness-focused consumers track vitamins, hormones, genetics, and metabolic markers through regular blood testing for long-term health management. Prenatal, newborn, athletic, and concierge medicine programs rely on blood collection tubes for screening, monitoring, and proactive healthcare services.

Restraints

Safety concerns and needle stick injuries are limiting market accessibility.

A major challenge in the blood collection tubes market involves needle stick injuries, exposing healthcare workers to blood-borne infections during blood collection. Busy hospitals increase injury risk when staff rush procedures, handle contaminated needles, or manage patient movement during blood sample collection. Exposure to hepatitis B, hepatitis C, or HIV creates serious health risks despite safety training, protective equipment, and post-exposure protocols. Regulations require safety-engineered blood collection devices with needle protection, thereby increasing manufacturing costs compared with traditional blood collection tube systems.

Errors during labeling, tube selection, or mixing cause sample rejection, patient recall, repeat blood draws, and higher diagnostic testing costs. Poor collection technique leads to hemolysis, damaged samples, inaccurate laboratory results, delayed diagnosis, and additional blood collection procedures. Pediatric blood collection adds difficulty due to small veins, anxiety, limited blood volume, and the need for specialized pediatric collection tubes. Single-use blood collection tubes support infection control, but increase medical waste, raising environmental concerns around plastic disposal in healthcare.

Opportunities

How is point-of-care testing creating growth potential for the blood collection tubes industry?

The blood collection tubes market is expected to benefit from healthcare's shift toward decentralized testing across clinics, pharmacies, urgent care centers, and home care settings. Point-of-care diagnostics use smaller blood volumes collected through finger stick methods and micro blood collection tubes beyond traditional laboratory venipuncture. Rapid diagnostic testing for infections, cardiac markers, and metabolic conditions increases demand for tubes compatible with portable analyzers delivering fast results. Home healthcare monitoring for chronic diseases relies on capillary blood collection tubes, enabling self-collection and mail-based laboratory testing.

Pharmacy health screenings and mobile clinics require portable blood-collection supplies to support cholesterol and glucose testing, as well as routine diagnostic testing, in community locations. Telemedicine services use home blood collection kits shipped to patients, supporting remote diagnosis through laboratory analysis of returned samples. Workplace health programs, emergency medical services, and sports medicine facilities depend on compact blood collection tubes for field testing needs. Veterinary diagnostics adopt advanced blood-collection tube technology for animal testing, thereby expanding market growth across the healthcare and life sciences sectors.

Challenges

How are supply chain disruptions and raw material costs creating obstacles for the blood collection tubes market?

The blood collection tubes market faces challenges from global supply chain weakness, raw material price changes, and limited manufacturing capacity, affecting availability. Plastic tube production depends on petroleum materials, with oil price swings increasing costs and reducing margins for blood collection tube manufacturers. Glass blood collection tube manufacturing requires specialized plants with limited capacity, creating supply bottlenecks during demand spikes or factory disruptions. Shortages of rubber stoppers, needles, additives, or packaging materials can stop final assembly and delay blood collection tube deliveries.

Sterile transport and careful handling increase logistics costs, whereas regulatory approvals across regions complicate the distribution of international blood collection tubes. Pandemic disruptions exposed shortages as testing demand exceeded production capacity, while hospitals using lean inventory faced rapid supply gaps. Counterfeit products and quality failures lead to recalls, safety risks, revenue losses, and damage to trust in the global blood collection tubes market.

Request Free Sample

Blood Collection Tubes Market: Report Scope

Blood Collection Tubes Market: Segmentation

The global blood collection tubes market is segmented based on product type, material, application, end-user, and region.

Based on product type, the global blood collection tubes industry is segregated into serum separating tubes, EDTA tubes, plasma separation tubes, heparin tubes, glucose tubes, and others. Serum separating tubes lead the market due to their widespread use in clinical chemistry testing, versatile application across multiple test types, and suitability for automated laboratory analyzers.

Based on material, the industry is segmented into glass, plastic, and PET material. Plastic dominates the market due to its shatter resistance, which improves safety; lighter weight, which reduces shipping costs; lower manufacturing costs compared with glass; and a growing preference among healthcare facilities for disposable plastic products.

Based on application, the global blood collection tubes market is classified into diagnostic testing, blood banking, clinical chemistry, immunology, molecular diagnostics, and hematology. Diagnostic testing is expected to lead the market during the forecast period due to its broad scope encompassing multiple test categories, high-volume routine testing, and an essential role in disease diagnosis and management.

Based on end-user, the global market is divided into hospitals, diagnostic laboratories, blood banks, research institutions, and home healthcare. Diagnostic laboratories hold the largest market share due to high daily testing volumes, specialized equipment for processing large sample batches, and efficiency advantages in routine diagnostic testing.

Blood Collection Tubes Market: Regional Analysis

What factors are contributing to North America's dominance in the global blood collection tubes market?

North America shows steady growth with about a 4.2% CAGR, remaining the leading region within the global blood collection tubes market. Strong healthcare infrastructure, high diagnostic testing volumes, mature laboratory networks, and strict regulations support the blood collection tubes market leadership across North America. The United States operates thousands of diagnostic laboratories processing millions of blood samples daily for screening, diagnosis, monitoring, and preventive healthcare programs. Advanced laboratory automation increases demand for specialized blood collection tubes compatible with analyzers, robotics, barcoding systems, and digital laboratory information platforms.

High healthcare spending per capita enables routine blood testing access through insurance coverage, supporting diagnostics as standard medical care. Growing elderly populations increase chronic disease prevalence, requiring frequent blood tests for diabetes, cardiovascular disease, kidney disorders, and cancer management. Preventive healthcare culture promotes annual physical examinations using comprehensive blood panels beyond acute illness diagnosis or emergency treatment. Large reference laboratories formed through consolidation have substantial testing volumes, which demand reliable blood-collection-tube supply chains and adequate inventory availability. Strict FDA and CLIA regulations enforce quality, sterility, labeling, and performance standards, favoring established blood collection tube manufacturers.

Clinical research organizations and pharmaceutical companies require specialized blood collection tubes supporting clinical trials, biomarker studies, and regulatory submissions. Point-of-care testing expansion across clinics, urgent care centers, and pharmacies increases blood collection tube usage outside traditional laboratories. Home healthcare services support self-collection, mobile phlebotomy, and courier transport, requiring simple blood collection tubes and safe packaging. Ongoing technology innovation improves safety features, sample integrity, automation compatibility, and efficiency within the North America blood collection tubes market. These combined factors maintain strong demand, stable growth, and continued regional dominance within the global blood collection tubes market.

Europe maintains a significant market share.

Europe is projected to grow at a 3.8% CAGR, remaining the second-largest region in the global blood collection tubes industry. Europe maintains a strong blood collection tubes market performance due to universal healthcare access, standardized quality systems, and advanced diagnostic infrastructure across countries. Germany, France, the United Kingdom, Italy, and neighboring nations operate extensive laboratory networks supporting hospitals, clinics, and specialized diagnostic centers region-wide. Universal healthcare coverage ensures routine diagnostic testing access across income groups, supporting consistent blood collection tube demand among diverse population segments.

Aging European populations experience rising chronic disease prevalence, increasing routine blood testing needs for long-term disease monitoring and treatment management. Preventive healthcare programs across Scandinavia and Western Europe promote regular screenings supporting early detection and continuous blood testing volumes. European Union medical device regulations provide harmonized quality standards, enabling efficient cross-border distribution and simplified market entry for manufacturers. Strong pharmaceutical and biotechnology industries conduct extensive clinical research requiring reliable blood collection tubes for trials and biomarker analysis. Blood donation programs maintain high participation rates, creating steady demand for tubes used in donor screening and infectious disease testing.

Occupational health laws require regular employee health surveillance and exposure testing, thereby supporting consistent use of blood collection tubes across industries. The growth of medical tourism across Europe increases diagnostic testing volumes among international patients seeking specialized healthcare services. Public health surveillance programs rely on blood testing for population health monitoring, outbreak detection, and disease prevention initiatives. Strong logistics networks support the reliable distribution of blood collection tubes across urban hospitals and rural healthcare facilities. Combined healthcare access, regulation, research strength, and sustainability focus support steady growth and long-term stability within the European blood collection tubes market.

Recent Market Developments

• In December 2025, Bio-Rad Laboratories, Poly Medicure Limited, and Sekisui Medical Co., Ltd. announced a strategic expansion initiative in the venous blood collection tubes market focused on enhanced sampling technology, automation integration, and improved supply resilience to support rising global diagnostic testing demand and streamline laboratory workflows.

Blood Collection Tubes Market: Competitive Analysis

The leading players in the global blood collection tubes market are-

• Becton
• Dickinson and Company
• Terumo Corporation
• Greiner Bio-One International GmbH
• SARSTEDT AG and Co. KG
• Improve Medical Instruments Co., Ltd.
• FL Medical srl
• Narang Medical Limited
• SEKISUI Medical Co. Ltd.
• Gong Dong Medical Technology Co., Ltd.
• TUD United Co. Ltd.
• Sanli Medical and Technological Development Co., Ltd.
• GPC Medical Ltd.
• Avantor Inc.
• Cardinal Health Inc.
• Medtronic plc.

The global blood collection tubes market is segmented as follows:

By Product Type

• Serum Separating Tubes
• EDTA Tubes
• Plasma Separation Tubes
• Heparin Tubes
• Glucose Tubes
• Others

By Material

• Glass
• Plastic
• PET Material

By Application

• Diagnostic Testing
• Blood Banking
• Clinical Chemistry
• Immunology
• Molecular Diagnostics
• Hematology

By End User

• Hospitals
• Diagnostic Laboratories
• Blood Banks
• Research Institutions
• Home Healthcare

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa